Delving into the Latest Updates on Shenzhen Haibowei Pharmaceutical Co., Ltd. with Synapse

Overview

主要目的：在健康成年受试者中评估HBW-004285单次给药和多次给药的安全性和耐受性；次要目的：在健康成年受试者中分别评估HBW-004285单次给药和多次给药后的药代动力学（PK）特征；评价食物对HBW-004285单次给药后药代动力学的影响；初步评价HBW-004285的代谢和排泄特征；评估HBW-004285对ECG参数的影响。

[Translation]

Primary objective: To evaluate the safety and tolerability of HBW-004285 after single and multiple administrations in healthy adult subjects; Secondary objectives: To evaluate the pharmacokinetic (PK) characteristics of HBW-004285 after single and multiple administrations in healthy adult subjects; To evaluate the effect of food on the pharmacokinetics of HBW-004285 after a single administration; To preliminarily evaluate the metabolism and excretion characteristics of HBW-004285; To evaluate the effect of HBW-004285 on ECG parameters.

Start Date20 Apr 2023

Sponsor / Collaborator

Shenzhen Haibowei Pharmaceutical Co., Ltd.

100 Clinical Results associated with Shenzhen Haibowei Pharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Shenzhen Haibowei Pharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with Shenzhen Haibowei Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Shenzhen Haibowei Pharmaceutical Co., Ltd.

Login to view more data